Jason Pitarresi

Jason Pitarresi is an Assistant Professor at UMass Chan Medical School's Department of Medicine. He holds multiple affiliate roles across institutions, including departments in Molecular, Cell and Cancer Biology, Cancer Biology, Immunology, and Translational Science programs. His research focuses on pancreatic cancer mechanisms, particularly cellular plasticity, metastasis, and immune interactions, with a strong emphasis on mitochondrial signaling and epithelial-mesenchymal transition (EMT). Pitarresi earned a BS from SUNY Geneseo and a PhD in Biochemistry from Ohio State University.

His work spans molecular mechanisms of cancer progression, including studies on PRRX1, FRA1, and mitochondrial calcium's role in tumor growth. Collaborations with co-authors like Rustgi, Stanger, and Fitzgerald highlight his interdisciplinary approach. Recent articles emphasize novel therapeutic strategies targeting cellular plasticity and immune evasion. His research also explores histone methylation, metabolic pathways, and nanoparticle-based immunotherapies, reflecting a broad impact on cancer biology and translational medicine.

Pitarresi’s publications (over 70 entries) reveal a focus on pancreatic ductal adenocarcinoma, acinar-to-ductal metaplasia, and therapeutic vulnerabilities. His work bridges basic science and clinical applications, with implications for immunotherapy and targeted drug development. Despite no explicitly listed awards, his prolific output and high-impact journals (Nature, Cell, Science) indicate significant scholarly recognition.

He contributes to multiple graduate programs, mentoring students in cancer biology and molecular mechanisms. His lab’s research integrates cell biology, genetics, and immunology to address critical questions in pancreatic cancer pathogenesis and therapy.